The parallels of Noonan/LZTR1 loss of function phenotypes with those in 22q11DS suggest it is a viable candidate for modulating core 22q11.2 anomalies in individuals with 3 Mb A to D deletions. The gene discussed is LZTR1; the disease is 22q11.2 deletion syndrome.